Literature DB >> 12401873

Aldactone therapy in a peritoneal dialysis patient with decreased left ventricular function.

Michael J Hausmann, Noah Liel-Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12401873     DOI： 10.1093/ndt/17.11.2035

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Long-term effects of spironolactone in peritoneal dialysis patients.

Authors:  Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hirofumi Tamai; Takeyuki Hiramatsu; Hiroshige Ohashi; Isao Ito; Hirotake Kasuga; Masanobu Horie; Shoichi Maruyama; Yukio Yuzawa; Tatsuaki Matsubara; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 2.  Mineralocorticoid receptor blockade in chronic kidney disease.

Authors:  Matthew J Volk; Andrew S Bomback; Philip J Klemmer
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

3.  Aldosterone-receptor antagonism and end-stage renal disease.

Authors:  Niall McLaughlin; Todd W B Gehr; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

4.  Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.

Authors:  Rafał Donderski; Paweł Stróżecki; Beata Sulikowska; Magdalena Grajewska; Ilona Miśkowiec; Anna Stefańska; Joanna Siódmiak; Grażyna Odrowąż-Sypniewska; Jacek Manitius
Journal:  Int Urol Nephrol       Date:  2017-07-14       Impact factor: 2.370
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.